APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Product

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Selected research

Market Outlook & Growth Opportunities

Global Blood Product Market Outlook and Growth Opportunities 2026

1 January 2026208 pages

Choose your research edition.

Industry ResearchBlood Product Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Product Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Product Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Product Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

This report provides an overview of the global Blood Product market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Blood Product and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Product revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Product market.

Blood Product Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co., Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Blood Product Segment by Type

Albumin

Immunoglobulin

Clotting Factor

Others

Blood Product Segment by Application

Bleeding Wound

Immunodeficiency

HBV

Tetanus

Rabies

Hemophilia

Others

Blood Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Product status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Product key companies, revenue, market share, and recent developments.

3. To split the Blood Product breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Product significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Product industry.

Chapter 3: Detailed analysis of Blood Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Product Industry Trends Table 2. Blood Product Industry Drivers Table 3. Blood Product Industry Opportunities and Challenges Table 4. Blood Product Industry Restraints Table 5. Global Blood Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Product Revenue Share by Company (2021-2026) Table 7. Global Blood Product Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Product Key Company Manufacturing Base & Headquarters Table 9. Global Blood Product Company, Product Type & Application Table 10. Global Blood Product Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Albumin Table 15. Significant Companies of Immunoglobulin Table 16. Significant Companies of Clotting Factor Table 17. Significant Companies of Others Table 18. Global Blood Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Blood Product Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Blood Product Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Blood Product Sales Value Share by Type (2021-2026) Table 22. Global Blood Product Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Bleeding Wound Table 24. Significant Companies of Immunodeficiency Table 25. Significant Companies of HBV Table 26. Significant Companies of Tetanus Table 27. Significant Companies of Rabies Table 28. Significant Companies of Hemophilia Table 29. Significant Companies of Others Table 30. Global Blood Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Blood Product Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Blood Product Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Blood Product Sales Value Share by Application (2021-2026) Table 34. Global Blood Product Sales Value Share by Application (2027-2032) Table 35. Global Blood Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Blood Product Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Blood Product Sales Value Share by Region (2021-2026) Table 38. Global Blood Product Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Blood Product Sales Value Share by Region (2027-2032) Table 40. Global Blood Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Blood Product Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Blood Product Sales Value Market Share by Country (2021-2026) Table 43. Global Blood Product Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Blood Product Sales Value Market Share by Country (2027-2032) Table 45. Takeda Company Information Table 46. Takeda Business Overview Table 47. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Takeda Blood Product Product Portfolio Table 49. Takeda Recent Development Table 50. CSL Company Information Table 51. CSL Business Overview Table 52. CSL Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. CSL Blood Product Product Portfolio Table 54. CSL Recent Development Table 55. Grifols Company Information Table 56. Grifols Business Overview Table 57. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Grifols Blood Product Product Portfolio Table 59. Grifols Recent Development Table 60. Octapharma Company Information Table 61. Octapharma Business Overview Table 62. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Octapharma Blood Product Product Portfolio Table 64. Octapharma Recent Development Table 65. Kedrion Company Information Table 66. Kedrion Business Overview Table 67. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Kedrion Blood Product Product Portfolio Table 69. Kedrion Recent Development Table 70. LFB Group Company Information Table 71. LFB Group Business Overview Table 72. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. LFB Group Blood Product Product Portfolio Table 74. LFB Group Recent Development Table 75. Biotest Company Information Table 76. Biotest Business Overview Table 77. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Biotest Blood Product Product Portfolio Table 79. Biotest Recent Development Table 80. BPL Company Information Table 81. BPL Business Overview Table 82. BPL Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BPL Blood Product Product Portfolio Table 84. BPL Recent Development Table 85. Shanghai RAAS Company Information Table 86. Shanghai RAAS Business Overview Table 87. Shanghai RAAS Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Shanghai RAAS Blood Product Product Portfolio Table 89. Shanghai RAAS Recent Development Table 90. China Biologic Products Company Information Table 91. China Biologic Products Business Overview Table 92. China Biologic Products Blood Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. China Biologic Products Blood Product Product Portfolio Table 94. China Biologic Products Recent Development Table 95. Hualan Biological Engineering Inc. Company Information Table 96. Hualan Biological Engineering Inc. Business Overview Table 97. Hualan Biological Engineering Inc. Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 98. Hualan Biological Engineering Inc. Blood Product Product Portfolio Table 99. Hualan Biological Engineering Inc. Recent Development Table 100. Beijing Tiantan Biological Products Corp Company Information Table 101. Beijing Tiantan Biological Products Corp Business Overview Table 102. Beijing Tiantan Biological Products Corp Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 103. Beijing Tiantan Biological Products Corp Blood Product Product Portfolio Table 104. Beijing Tiantan Biological Products Corp Recent Development Table 105. Pacific Shuanglin Company Information Table 106. Pacific Shuanglin Business Overview Table 107. Pacific Shuanglin Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 108. Pacific Shuanglin Blood Product Product Portfolio Table 109. Pacific Shuanglin Recent Development Table 110. Boya Bio-Pharmaceutical Company Information Table 111. Boya Bio-Pharmaceutical Business Overview Table 112. Boya Bio-Pharmaceutical Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 113. Boya Bio-Pharmaceutical Blood Product Product Portfolio Table 114. Boya Bio-Pharmaceutical Recent Development Table 115. Paisi Feike Biology Pharmacy Co., Ltd. Company Information Table 116. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview Table 117. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development Table 120. Xinjiang Deyuan Bioengineering Company Information Table 121. Xinjiang Deyuan Bioengineering Business Overview Table 122. Xinjiang Deyuan Bioengineering Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 123. Xinjiang Deyuan Bioengineering Blood Product Product Portfolio Table 124. Xinjiang Deyuan Bioengineering Recent Development Table 125. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information Table 126. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview Table 127. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development Table 130. Shenzhen Weiguang Company Information Table 131. Shenzhen Weiguang Business Overview Table 132. Shenzhen Weiguang Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 133. Shenzhen Weiguang Blood Product Product Portfolio Table 134. Shenzhen Weiguang Recent Development Table 135. Shanxi Kangbao Company Information Table 136. Shanxi Kangbao Business Overview Table 137. Shanxi Kangbao Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 138. Shanxi Kangbao Blood Product Product Portfolio Table 139. Shanxi Kangbao Recent Development Table 140. Nanyue Biopharming Corporation Ltd Company Information Table 141. Nanyue Biopharming Corporation Ltd Business Overview Table 142. Nanyue Biopharming Corporation Ltd Blood Product Sales (K Bottles), Value (US$ Million), Price (US$/Bottle) and Gross Margin (2021-2026) Table 143. Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio Table 144. Nanyue Biopharming Corporation Ltd Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Blood Product Product Image Figure 2. Global Blood Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Product Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Albumin Image Figure 8. Immunoglobulin Image Figure 9. Clotting Factor Image Figure 10. Others Image Figure 11. Global Blood Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Blood Product Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Blood Product Sales Value Share by Type (2021-2032) Figure 14. Bleeding Wound Image Figure 15. Immunodeficiency Image Figure 16. HBV Image Figure 17. Tetanus Image Figure 18. Rabies Image Figure 19. Hemophilia Image Figure 20. Others Image Figure 21. Global Blood Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Blood Product Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Blood Product Sales Value Share by Application (2021-2032) Figure 24. Global Blood Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Blood Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Blood Product Sales Value (2021-2032) & (US$ Million) Figure 27. North America Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Blood Product Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Blood Product Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Blood Product Sales Value (2021-2032) & (US$ Million) Figure 33. South America Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Blood Product Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Blood Product Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Blood Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Blood Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Blood Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immunoglobulin
  • Clotting Factor
  • Others
Applications
  • Bleeding Wound
  • Immunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • Shanghai RAAS
  • China Biologic Products
  • Hualan Biological Engineering Inc.
  • Beijing Tiantan Biological Products Corp
  • Pacific Shuanglin
  • Boya Bio-Pharmaceutical
  • Paisi Feike Biology Pharmacy Co., Ltd.
  • Xinjiang Deyuan Bioengineering
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Shenzhen Weiguang
  • Shanxi Kangbao
  • Nanyue Biopharming Corporation Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Product Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Product Market Dynamics
  1. 2.1 Blood Product Industry Trends
  2. 2.2 Blood Product Industry Drivers
  3. 2.3 Blood Product Industry Opportunities and Challenges
  4. 2.4 Blood Product Industry Restraints
3 Blood Product Market by Company
  1. 3.1 Global Blood Product Company Revenue Ranking in 2025
  2. 3.2 Global Blood Product Revenue by Company (2021-2026)
  3. 3.3 Global Blood Product Company Ranking (2024-2026)
  4. 3.4 Global Blood Product Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Product Company Product Type and Application
  6. 3.6 Global Blood Product Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Product Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Product Market by Type
  1. 4.1 Blood Product Type Introduction
  2. 4.1.1 Albumin
  3. 4.1.2 Immunoglobulin
  4. 4.1.3 Clotting Factor
  5. 4.1.4 Others
  6. 4.2 Global Blood Product Sales Value by Type
  7. 4.2.1 Global Blood Product Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Blood Product Sales Value by Type (2021-2032)
  9. 4.2.3 Global Blood Product Sales Value Share by Type (2021-2032)
5 Blood Product Market by Application
  1. 5.1 Blood Product Application Introduction
  2. 5.1.1 Bleeding Wound
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 HBV
  5. 5.1.4 Tetanus
  6. 5.1.5 Rabies
  7. 5.1.6 Hemophilia
  8. 5.1.7 Others
  9. 5.2 Global Blood Product Sales Value by Application
  10. 5.2.1 Global Blood Product Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Blood Product Sales Value by Application (2021-2032)
  12. 5.2.3 Global Blood Product Sales Value Share by Application (2021-2032)
6 Blood Product Regional Value Analysis
  1. 6.1 Global Blood Product Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Product Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Product Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Product Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Product Sales Value (2021-2032)
  7. 6.3.2 North America Blood Product Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Product Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Product Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Product Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Product Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Product Sales Value (2021-2032)
  16. 6.6.2 South America Blood Product Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Product Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Product Sales Value Share by Country, 2025 VS 2032
7 Blood Product Country-level Value Analysis
  1. 7.1 Global Blood Product Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Product Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Product Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Product Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Product Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Product Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Product Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Product Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Product Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Product Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Product Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Product Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Product Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Product Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Product Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Product Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Product Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Product Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Product Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Product Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Product Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Product Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Product Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Product Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Product Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Product Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Product Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Product Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Product Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Product Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Product Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Product Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Product Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Product Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Product Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Product Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Product Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Product Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Product Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Product Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Product Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Product Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Product Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Product Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Product Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Product Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Product Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Product Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Product Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Product Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Product Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Product Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Product Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Product Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Product Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Product Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Product Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Product Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Product Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Product Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Product Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Product Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Product Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Product Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Product Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Product Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Product Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Product Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Product Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Product Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Product Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Product Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Product Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Product Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Product Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Product Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Product Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Product Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Product Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Product Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Product Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Product Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Product Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Product Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Product Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Blood Product Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Blood Product Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Blood Product Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Blood Product Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Blood Product Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Blood Product Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Blood Product Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Blood Product Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Blood Product Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Blood Product Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group Blood Product Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group Blood Product Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Biotest
  38. 8.7.1 Biotest Company Information
  39. 8.7.2 Biotest Business Overview
  40. 8.7.3 Biotest Blood Product Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biotest Blood Product Product Portfolio
  42. 8.7.5 Biotest Recent Developments
  43. 8.8 BPL
  44. 8.8.1 BPL Company Information
  45. 8.8.2 BPL Business Overview
  46. 8.8.3 BPL Blood Product Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BPL Blood Product Product Portfolio
  48. 8.8.5 BPL Recent Developments
  49. 8.9 Shanghai RAAS
  50. 8.9.1 Shanghai RAAS Company Information
  51. 8.9.2 Shanghai RAAS Business Overview
  52. 8.9.3 Shanghai RAAS Blood Product Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai RAAS Blood Product Product Portfolio
  54. 8.9.5 Shanghai RAAS Recent Developments
  55. 8.10 China Biologic Products
  56. 8.10.1 China Biologic Products Company Information
  57. 8.10.2 China Biologic Products Business Overview
  58. 8.10.3 China Biologic Products Blood Product Revenue and Gross Margin (2021-2026)
  59. 8.10.4 China Biologic Products Blood Product Product Portfolio
  60. 8.10.5 China Biologic Products Recent Developments
  61. 8.11 Hualan Biological Engineering Inc.
  62. 8.11.1 Hualan Biological Engineering Inc. Company Information
  63. 8.11.2 Hualan Biological Engineering Inc. Business Overview
  64. 8.11.3 Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Biological Engineering Inc. Blood Product Product Portfolio
  66. 8.11.5 Hualan Biological Engineering Inc. Recent Developments
  67. 8.12 Beijing Tiantan Biological Products Corp
  68. 8.12.1 Beijing Tiantan Biological Products Corp Company Information
  69. 8.12.2 Beijing Tiantan Biological Products Corp Business Overview
  70. 8.12.3 Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Tiantan Biological Products Corp Blood Product Product Portfolio
  72. 8.12.5 Beijing Tiantan Biological Products Corp Recent Developments
  73. 8.13 Pacific Shuanglin
  74. 8.13.1 Pacific Shuanglin Company Information
  75. 8.13.2 Pacific Shuanglin Business Overview
  76. 8.13.3 Pacific Shuanglin Blood Product Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pacific Shuanglin Blood Product Product Portfolio
  78. 8.13.5 Pacific Shuanglin Recent Developments
  79. 8.14 Boya Bio-Pharmaceutical
  80. 8.14.1 Boya Bio-Pharmaceutical Company Information
  81. 8.14.2 Boya Bio-Pharmaceutical Business Overview
  82. 8.14.3 Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boya Bio-Pharmaceutical Blood Product Product Portfolio
  84. 8.14.5 Boya Bio-Pharmaceutical Recent Developments
  85. 8.15 Paisi Feike Biology Pharmacy Co., Ltd.
  86. 8.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
  87. 8.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
  88. 8.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Portfolio
  90. 8.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
  91. 8.16 Xinjiang Deyuan Bioengineering
  92. 8.16.1 Xinjiang Deyuan Bioengineering Company Information
  93. 8.16.2 Xinjiang Deyuan Bioengineering Business Overview
  94. 8.16.3 Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xinjiang Deyuan Bioengineering Blood Product Product Portfolio
  96. 8.16.5 Xinjiang Deyuan Bioengineering Recent Developments
  97. 8.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  98. 8.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Portfolio
  102. 8.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Shenzhen Weiguang
  104. 8.18.1 Shenzhen Weiguang Company Information
  105. 8.18.2 Shenzhen Weiguang Business Overview
  106. 8.18.3 Shenzhen Weiguang Blood Product Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shenzhen Weiguang Blood Product Product Portfolio
  108. 8.18.5 Shenzhen Weiguang Recent Developments
  109. 8.19 Shanxi Kangbao
  110. 8.19.1 Shanxi Kangbao Company Information
  111. 8.19.2 Shanxi Kangbao Business Overview
  112. 8.19.3 Shanxi Kangbao Blood Product Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shanxi Kangbao Blood Product Product Portfolio
  114. 8.19.5 Shanxi Kangbao Recent Developments
  115. 8.20 Nanyue Biopharming Corporation Ltd
  116. 8.20.1 Nanyue Biopharming Corporation Ltd Company Information
  117. 8.20.2 Nanyue Biopharming Corporation Ltd Business Overview
  118. 8.20.3 Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Nanyue Biopharming Corporation Ltd Blood Product Product Portfolio
  120. 8.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst